Regorafenib combined with irinotecan as second-line treatment in patients with metastatic gastro-oesophageal adenocarcinomas: A randomized phase 2 trial (PRODIGE 58 – UCGI 35 – REGIRI)

Bibliographic Details

Published in:	Annals of oncology 2019-07, Vol.30, p.iv21-iv21
Main Authors:	Samalin, E., Turpin, A., Khemissa, F., Zaanan, A., Benabdelghani, M., Senellart, H., Gilabert, M., Evesque, L., Dahan, L., Sefrioui, D., Bouché, O., De la Fouchardière, C., Hennequin, A., Monard, L., Gourgou, S., Lopez, A.
Format:	Article
Language:	eng
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!